Cardiac Rehabilitation Programs

Cardiac rehabilitation is a structured, medically supervised program designed to support recovery and reduce risk after a heart event or diagnosis. This page covers the definition and scope of these programs, how they function across distinct phases, the clinical scenarios that make a patient eligible, and the decision boundaries that determine program type, duration, and intensity. Understanding what cardiac rehabilitation actually involves — and what it does not — helps patients, families, and referring clinicians set accurate expectations.

Definition and scope

Cardiac rehabilitation programs are multidisciplinary outpatient interventions combining supervised exercise, cardiovascular risk factor education, nutritional counseling, psychosocial support, and medication management guidance. The Centers for Medicare & Medicaid Services (CMS) defines cardiac rehabilitation as a physician-supervised program consisting of individualized exercise therapy, education, and psychosocial assessment, and CMS covers the benefit for qualifying diagnoses under defined coverage criteria.

The American Association of Cardiovascular and Pulmonary Rehabilitation (AACPR) provides program certification standards that establish minimum performance requirements for staffing ratios, emergency equipment, patient assessment protocols, and outcome tracking. The AACPR publishes program certification criteria that certified facilities must renew on a multi-year cycle.

Scope varies by delivery model. Traditional cardiac rehabilitation is delivered in a supervised outpatient clinical setting, typically in 36 sessions over 12 weeks, as recognized by CMS. Intensive Cardiac Rehabilitation (ICR) — a distinct CMS-covered category — provides a more comprehensive program over a longer session count, up to 72 one-hour sessions over 18 weeks, through specific programs such as the Ornish Program for Reversing Heart Disease or the Pritikin Program, which must receive individual CMS approval as qualifying ICR programs. Home-based cardiac rehabilitation has expanded in availability, and the American Heart Association (AHA) has published position statements supporting home-based models as equivalent in safety and efficacy for appropriately selected low-risk patients.

For broader context on how cardiac care is organized at the regulatory and institutional level, see the regulatory context for cardiology resource on this site.

How it works

Cardiac rehabilitation programs are structured across three to four defined phases:

Phase I (Inpatient): Initiated during the hospital stay following a cardiac event. Activities are limited to low-level ambulation, breathing exercises, and patient education. Duration is typically 2–5 days depending on clinical stability.
Phase II (Outpatient Supervised): The primary covered benefit under CMS. Patients attend supervised sessions at a certified facility, where each session includes monitored aerobic exercise (commonly 20–40 minutes of continuous or interval activity), vital sign monitoring via continuous or spot-check electrocardiography, and individualized counseling. Intensity is set using target heart rate ranges derived from a baseline exercise test or established risk stratification formulas.
Phase III (Community or Transitional): A less formally supervised setting, often a fitness center or community program with periodic clinical check-ins. Insurance coverage is inconsistent at this phase. The American College of Cardiology (ACC) supports maintenance exercise programs as part of long-term secondary prevention.
Phase IV (Long-term Maintenance): Independent self-managed exercise aligned with the lifestyle targets established in earlier phases, with periodic reassessment by a cardiologist or primary care provider.

Each session in Phase II is staffed according to AACPR guidelines, which require at minimum a registered nurse or allied health professional trained in advanced cardiac life support (ACLS), along with emergency defibrillation equipment on site. Patient-to-staff ratios are capped by facility certification standards to allow safe monitoring.

Common scenarios

CMS-covered indications for Phase II cardiac rehabilitation include a defined list of qualifying diagnoses and procedures. Eligible conditions include:

Acute myocardial infarction within the preceding 12 months
Coronary artery bypass graft surgery (see Coronary Artery Bypass Surgery for procedural context)
Current stable angina pectoris
Heart valve repair or replacement
Percutaneous transluminal coronary angioplasty or coronary stenting
Heart or heart-lung transplantation
Stable, chronic heart failure (added as a covered indication effective January 2014 under Section 10406 of the Affordable Care Act, as noted in the CMS Medicare Coverage Database NCD 20.10.1)

Referral typically originates from the treating cardiologist or cardiovascular surgeon at or shortly after hospital discharge. Research published in the Journal of the American College of Cardiology has demonstrated that participation in cardiac rehabilitation following myocardial infarction is associated with reductions in all-cause mortality and hospital readmission rates, though absolute effect sizes vary by study design and population.

Patients managing long-term cardiovascular conditions can find additional detail on exercise reintroduction at exercise after a heart event and on daily management strategies at managing heart failure day-to-day.

Decision boundaries

Cardiac rehabilitation type, intensity, and setting are determined by risk stratification at program entry. The AACPR and AHA jointly recognize a three-tier classification system for cardiac rehabilitation patients:

Low risk: Uncomplicated recovery, preserved left ventricular ejection fraction (LVEF ≥ 50%), no resting or exercise-induced ischemia, and no complex arrhythmias. These patients may be candidates for home-based models.
Moderate risk: Mildly reduced LVEF (40–49%), moderate exercise capacity limitations, or prior but stable arrhythmia history. Supervised outpatient setting is preferred.
High risk: LVEF below 35–40%, exercise-induced ischemia, hemodynamic instability, or complex ventricular arrhythmias. Continuous ECG monitoring during each session is clinically indicated; some patients require deferral until stabilized.

Contraindications to initiating Phase II include unstable angina, uncontrolled arrhythmias, decompensated heart failure, severe aortic stenosis, and active myocarditis, as specified in AACPR clinical guidelines.

The distinction between standard cardiac rehabilitation (36 sessions) and Intensive Cardiac Rehabilitation (72 sessions) is not determined solely by clinical severity — ICR programs are defined by their specific approved curricula rather than by patient risk level. A patient who qualifies for cardiac rehabilitation does not automatically qualify for ICR; the treating physician must refer specifically to a CMS-approved ICR program.

Program completion rates vary significantly across demographic and geographic groups. The Agency for Healthcare Research and Quality (AHRQ) has identified referral gaps — particularly among women, older adults, and rural patients — as a systemic access problem rather than a clinical eligibility issue. For a comprehensive overview of cardiology topics covered across this resource, see the cardiology home page.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)